very the good Thanks, to share call. It everyone the launch of to progress XENLETA me details exciting with first we is on the great are in weeks for afternoon Ted, our on and making market.
in an about generating department day outpatient oral get be treated initially emergency patients get Most they and outpatient treated CABP transition to for Before in the or many XXX,XXX building are with an hospital, are significant in treated observation XENLETA. million or shows CABP admitted setting, three X.X either treatment. the care, patients in some further of IV and then patient who where but annually CABP at and an then treated alternatively, department, get XX in in States, unit CABP pneumonia, emergency not about the with can admitted patients hospital going launch and for slide annually, as we see opportunities and present and as directly diagnosed metric into get oral do an the on hospital details, message discharge with treated on drug, Ted's presented an of United distinct with a treatment
All the of a oral X.X IV three million an stay average indication profile four patients opportunity eventually confirm transition after compelling very given the its drug hospital department oral and in about the represent Consistent treated emergency of an the with that outpatient for get of days. view, discharged from to availability. and initial on care XENLETA, the pre-launch our
XENLETA's than and a the proposition to about medical and X.X business community physician CABP capitalize target these about given unmet a account. opportunity. need the million high managed access the tell more to treated are educating patients I'll on outstanding plans at our adjacent it's more prescribing office who X,XXX and care primary care represent in hospital our Finally, are important very patients key significant community-based with you our certainly value by
efficient of to way flu the and an developed the have upcoming effective enter We ahead immediately community season.
work how XX, for our to preparation I'd slide we the for like will to to a XX solid launch. foundation priorities days extensive successful first continue a Turning leveraging build the and highlight launch XENLETA
care patients The the first the at a in for support ensuring distribution to availability channel, discharge. launch is XENLETA for successful order foundational priority of in transition strategy
force connects placement profile priority with second formulary ensuring accelerate transition The sales prioritize the care. and our XENLETA to of is accounts
accounts. is affairs incredible added formulary restriction key The commercial both prioritized ensure pre-approval priority by key limited work plans. medical or accelerating to And with on third commercial that Medicare and no leveraging priority the and is the XENLETA formularies finally, fourth reviews is done hospital on at teams the the
to prescribe hospital to patients in environment setting. launch care goal to both for in for successful solid physician and the the build XENLETA transition right focus continue the a near-term primary of and confidently foundation Our our and the create is CABP
have six launch made on review foundational after weeks the priorities. progress just Let's we these
which Specialty weeks immediately their Health after McKesson obtaining job United after in XX, secured Specialty supply specialty slide the Walgreens XENLETA Care to and Cardinal team of Option Biologics at XENLETA's chain in extraordinary the an product. ensuring were to Community did the focuses three availability and launch Nabriva on and able distributors States Moving Plasma approval, planning and availability, Pharmacy all adequate at We the on the regulatory and launch just location. order also inventory ASD,
we strategy. date, established than we for Consistent that or specialty in patient XENLETA medical where launch, during one these profiled dosing. and support academic from assistant prior leading More is HUB in most Rx have hospital, outpatient to the Nabriva the the initial assistant, pharmacies, transition centers place of priority XX activities majority by To all of the to order, program collaboration and pre-commercial Connect than all transition formulary of supporting Transition McKesson between orders XENLETA pharmacies. review Rx orders came initial XXX and hospital orders more care an for to and Crossroads co-pay account. with expectation, To a bridge with initiate key our strategy the successful services, care
and tell force XX, completed they I'd you slide the the like On far. sales key Nabriva activities about to briefly so had
professionals. First and an in of average of able target them TBMs, average hospital experienced more years engaged made The calls XX attract the connected of hospitals. ID Today, have off, Managers hospital and product. and to have with had access XX.X has the have highly Business years healthcare sales or X,XXX an with X.X XXX all we team in-depth hospital with the majority selling been all XX% experience sales than over TBMs Territory with X,XXX ID experience
hospital a a the XXX now compared XX, medical slide X Nabriva within six exceed the we This either the higher recently And quarter pending hospital engagement, pre-approval of of end the Priority launched reviews. months to XXX paired access Business end affairs might and XENLETA the Most over large Territory of the hospital formulary XXXX. XXXX, Managers December, reviews to by by expect systems trend we by achieve hospital or account. accounts formerly to as the antibiotics. first have all result commercial of we are work total scheduled first profiling that review to of indicate Turning of teams, a done with the
approximately work our slide pre-approval, just million meetings great on total that I'm covered with on the team progress extensive really access or thrilled key team in Moving to to payer weeks. conducted has account made Based representing with has of XX, approval the share since few approximately market short a done lives the lives XXX date. you the XX%
within As the had result the level a of engagement, occur reviews this have clinical majority first of for days of of launch. to XX occurred expected XENLETA or
covered or million XXX of Edits XX% required. no lives approximately have utilization date, access either Step the Authorization To with having majority management to Prior XENLETA
formularies had time. to established such is by driven while period their utilization a Part and remarkable Coverage coverage. D with Medicare a Scripts is a short takes primarily generally XENLETA management. in commercial again, no Anthem This Express accomplishment who of to
driven you Part However, see already coverage some adding prior with D authorization. formulary, by can again the we Pfizer primarily XENLETA do to no have
We certain lives with XX Medicaid for coverage date, commercial and commercial had states no also in To with are Part and key and we already approximately utilization of D wins management. D contracting under About Part are have million utilization contract. XX% no have all plan management Medicare with in some the process Medicare plans.
first to the review next quarter more XXXX. few by We months XX% with total end expected covered of of the expect increase coverage over of lives XENLETA than to further the
outpatient opportunity to IV effective granted Medicare have October has reimbursement enable bill December an for X% to by XX expected XX, Turning an for status Code at XENLETA transition increased for submitted XXXX. departments the XENLETA. we IV. J a XENLETA Application be will anticipate with been Code X We pass will for by that for on for care XENLETA January the slide through that C plus approval of ASP
would for With basis for code commercial Medicare plan bill IV. review CMS allow on for the codes a this January the date outpatient implementation could and is possibility to J an it permanent There quarterly a that and code XENLETA. of of expedite department a and at with new X% J will the plus award ASP XENLETA effective XXXX,
Moving on I'd the share launch to XENLETA to slide XX, pull focused on like through. priorities,
substantial Nabriva is in customers using drive of a inpatient, giving care transitional goal settings. to Our outpatient XENLETA orders new reorders hospital and and foundation the
further key to We with continue to expand to access D will finalize P&T hospital and commercial Part Medicare accounts review of to contracts secure will continue XENLETA and work XENLETA.
utilization formulary pull We will priority accounts patient. the high appropriate the drive to at prior through and initial purchase for and review
We and will consistent focus to effort November, in and In effective community those XENLETA its an have setting in strategy. the focused we launched with with XENLETA. focus care a of community, the into Nabriva on way maximizing take of utilization the the efficient who hospital our transition first early step commercial infrastructure for
to well force significant flu and experience program take the Moving community. utilize our It more on hospital in to as treatment big focused professionals the high advantage the close XX-year X,XXX CABP current resistant hospital prescribers slide location. than for of community XX, healthcare community and targets are are oral to pneumonia field target that proximity to of oral season, antibiotic our within as
and primary drugs This This loop concerned physicians. will new helps macrolide. hospital and provide us opens living also may new who outpatient the physician, on for as XENLETA more option fluoroquinolone with in on care close existing using a opportunity with be such
Nabriva force efficiently will impact and primary we believe the XENLETA. our allow physician to to those hospital, for targeting our access close By opportunity maximize community us are potential will high in proximity care target with who field
We are which adoption to Rx remove XENLETA services support and the community. community effort shipping appropriate directly expanding Connect in to by barriers additional also the the patient, should the through the uptake Nabriva
in At Nabriva, very about are convinced we we the forward And next launch, to days XENLETA launch. progress to earnings with have are additional with and moving successful all at look direction made information great in our that are our very have call. we sharing the a we you early the I excited right
over like to Gary? turn Gary review. financial to now the presentation would for I the
